Corporate Relations
There are a number of ways in which companies can leverage their resources through a relationship with Stanford Medicine.
Support faculty, students, or facilities through a broad partnership
By making gifts to Stanford Medicine, corporations strengthen their relationship with one of the world's leading research universities, support departments and faculty engaged in research related to their interests, honor individuals who have played key roles in their success, introduce their companies and their products to future users, and support and encourage the philanthropy of their employees. For more information, contact Joy Morimoto, Director of Corporate and Foundation Relations, at 650.736.9749 or joym@stanford.edu.
License specific technology
Stanford's licensing activities involve inventions, patents, biological materials, software, equipment, and copyrightable materials. By working closely with inventors and industry, Stanford seeks to maximize the value of technology for the future. Technology transfer has become a key concept in national, regional, and global economic development. In the entrepreneurial environment of Silicon Valley, Stanford University and its Office of Technology Licensing (OTL) have become models for successful technology transfer. For more information, contact the Office of Technology Licensing .
Sponsor research
As a major research university, Stanford receives a significant portion of its funding from organizations that sponsor research by financially underwriting projects at Stanford. Usually awarded upon submission and evaluation of a proposal, sponsored projects typically include a statement of work, a budget, and terms for the disposition of resulting tangible and intangible property.
Why might industry contract out their research efforts to a university? The answers are as varied as the intellectual questions behind the projects; however we believe the answer is a desire to make the best use of limited corporate resources, to take advantage of unique research facilities, and to engage faculty and students in questions which will impact the future of the world. For more information, contact the Industrial Contracts Office .
Sponsor clinical trials
Clinical trials are ongoing at Stanford Medicine involving pharmaceutical, biotechnology, and medical device therapeutics. The clinical faculty participate in Phase I, II, and III clinical trials, as well as industry-sponsored preclinical research and human subjects studies for new indications for approved drugs (Phase IV). Many clinical trials are part of a multi-center format, and Stanford has served as the organizing site for some of these trials. For more information, contact:
- Non-cancer studies:
Linda Walker, Program Manager, Spectrum, at lswalker@stanford.edu or 650.498.6498 - For cancer-related trials:
The Cancer Clinical Trials Office (CCTO) at ccto-website@stanford.edu or 650.724.0153.
Support a faculty member's research
Contact us
For more information, please contact:
Joy Morimoto
Assistant Vice President
Medical Center Development
Corporate and Foundation Relations
650.736.9749
joym@stanford.edu